Hybrid
The Plaque Strikes Back: Aspirin versus Clopidogrel for Secondary Prevention of Coronary Artery Disease
Hosted by Department of Veterans Affairs (VA), Veterans Health Administration (VHA)
Jun 11, 2026 Albuquerque, New Mexico
About This Event
This CME activity examines the comparative efficacy of aspirin versus clopidogrel as single antiplatelet therapy for secondary prevention of coronary artery disease. Pharmacists and pharmacy technicians will review current evidence on whether clopidogrel demonstrates superiority over aspirin in cardiovascular outcomes when transitioning from dual antiplatelet therapy after acute coronary syndrome events.
Sign in to unlock everything networkED.global adds to this event
We enrich every event with details scattered across the web — organized, verified, in one place:
- Earning CE? CE credits, accreditation, and which licenses it counts toward — tracked automatically.
- Speaking? Call-for-proposal deadlines and submission details.
- Exhibiting or sponsoring? Exhibit and sponsorship opportunities.
- Hosting events? Be connected directly to your target audiences.
Plus full agenda, pricing, registration, contacts, and topics covered.
Venue
Albuquerque, New Mexico
View on Google Maps